Yahoo
OTC Markets OTCPK - Delayed Quote USD

Manhattan Scientifics, Inc. (MHTX)

0.0001 0.0000 (0.00%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for MHTX
  • Previous Close 0.0001
  • Open 0.0001
  • Bid 0.0005 x --
  • Ask 0.0007 x --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0000 - 0.0001
  • Volume 4,556,332
  • Avg. Volume 5,041
  • Market Cap (intraday) 55,928
  • Beta (5Y Monthly) 24.59
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.

mhtx.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MHTX
0.00%
S&P 500 (^GSPC)
7.76%

1-Year Return

MHTX
0.00%
S&P 500 (^GSPC)
9.77%

3-Year Return

MHTX
97.73%
S&P 500 (^GSPC)
68.96%

5-Year Return

MHTX
99.56%
S&P 500 (^GSPC)
57.04%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -132.78%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -1.06M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    38k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    146.12k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: